BostonGene to Present 13 Abstracts at Cancer Research Conference

The biotech company will showcase its latest oncology research findings at the AACR Annual Meeting 2026.

Apr. 9, 2026 at 4:37pm

Got story updates? Submit your updates here. ›

A translucent, ghostly X-ray photograph revealing the intricate structure of a microscopic cancer cell, glowing with an inner light against a dark background, conceptually representing the complex biological mechanisms behind cancer.BostonGene's cutting-edge cancer research aims to unlock the secrets of tumor biology and pave the way for more personalized treatment options.Waltham Today

BostonGene, a leading biotechnology company focused on molecular and immune profiling for cancer treatment selection, announced that it will present 13 abstracts at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2026. The conference, one of the premier oncology research events, will take place in Waltham, Massachusetts.

Why it matters

BostonGene's presentations at the AACR Annual Meeting will highlight the company's advancements in precision oncology, which aim to improve cancer treatment selection and outcomes for patients. As a prominent player in the field of molecular and immune profiling, BostonGene's research contributions at this high-profile conference could lead to further breakthroughs in personalized cancer care.

The details

The 13 abstracts BostonGene will present at the AACR Annual Meeting 2026 cover a range of oncology research topics, including novel biomarker discoveries, advancements in tumor profiling techniques, and the development of innovative treatment strategies. These findings have the potential to inform future cancer diagnostics and therapeutics.

  • The AACR Annual Meeting 2026 will take place from April 11-15, 2026.
  • BostonGene will present its 13 abstracts during the conference.

The players

BostonGene

A leading biotechnology company focused on molecular and immune profiling for cancer treatment selection.

American Association for Cancer Research (AACR)

A premier oncology research organization that hosts the annual AACR Annual Meeting, one of the top conferences in the field of cancer research.

Got photos? Submit your photos here. ›

What’s next

The findings presented by BostonGene at the AACR Annual Meeting 2026 will be closely watched by the oncology research community, as they have the potential to drive advancements in personalized cancer care.

The takeaway

BostonGene's strong presence at the AACR Annual Meeting 2026 underscores the company's commitment to advancing precision oncology through innovative research and technology. These presentations could lead to further collaborations and breakthroughs in the field of cancer diagnostics and therapeutics.